The objective of the program is to acquire a specialized knowledge in health economics and market access to understand the global process of launching new compounds in different markets. The main skills and topics are related with global portfolios, definition, activities and budgeting in new drug developments, pricing, National Healthcare System and FDA and EMA Markets.
Pre-selection process: closed
Inscriptions Open: from October 2018 to January 2019
The students of our programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
Credits - 30 / European ECTS credits
Postgraduate Programs – 4th February 2019 to 30th May 2019.
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English